Sudden infant death syndrome: study of genes pertinent to cardiorespiratory and autonomic regulation
暂无分享,去创建一个
[1] D. Tester,et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. , 2007, Heart rhythm.
[2] Michael J Ackerman,et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. , 2007, Heart rhythm.
[3] Dan M Roden,et al. Cardiac potassium channel dysfunction in sudden infant death syndrome. , 2007, Journal of molecular and cellular cardiology.
[4] Peter J. Schwartz,et al. Prevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome , 2007, Circulation.
[5] S. Priori,et al. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. , 2006, European heart journal.
[6] E. Berry-Kravis,et al. Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. , 2006, American journal of respiratory and critical care medicine.
[7] Michael J Ackerman,et al. Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome , 2006, Circulation.
[8] Amy E. Chadwick,et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. , 2006, JAMA.
[9] B. Maher,et al. Sudden infant death syndrome: Case‐control frequency differences in paired like homeobox (PHOX) 2B gene , 2006, American journal of medical genetics. Part A.
[10] W. Budts,et al. Prevalence of cardiovascular risk factors in adults with congenital heart disease , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[11] B. Maher,et al. 3′ UTR polymorphism of the serotonin transporter gene and sudden infant death syndrome: Haplotype analysis , 2006, American journal of medical genetics. Part A.
[12] B. Maher,et al. Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome , 2006, American journal of medical genetics. Part A.
[13] S. L. Murphy,et al. Deaths: final data for 2003. , 2006, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[14] Matthew W State,et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. , 2006, The Journal of clinical investigation.
[15] D. Tester,et al. Sudden infant death syndrome: how significant are the cardiac channelopathies? , 2005, Cardiovascular research.
[16] P. Sham,et al. The serotonin transporter gene as a QTL for ADHD , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[17] A. Munnich,et al. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. , 2005, American journal of human genetics.
[18] Jørgen K. Kanters,et al. Mutations in the HERG K+-ion channel: a novel link between long QT syndrome and sudden infant death syndrome. , 2005, The American journal of cardiology.
[19] Johnf . Thompson,et al. Role of a KCNH2 polymorphism (R1047 L) in dofetilide-induced Torsades de Pointes. , 2004, Journal of molecular and cellular cardiology.
[20] J. Stephens,et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. , 2004, Heart rhythm.
[21] Lili Zhou,et al. Sudden Infant Death Syndrome: Case-Control Frequency Differences at Genes Pertinent to Early Autonomic Nervous System Embryologic Development , 2004, Pediatric Research.
[22] François Guillemot,et al. Ascl1/Mash1 is required for the development of central serotonergic neurons , 2004, Nature Neuroscience.
[23] M. Ackerman,et al. Cardiac channelopathies: it's in the genes , 2004, Nature Medicine.
[24] K. Hayasaka,et al. Sudden infant death syndrome is not associated with the mutation of PHOX2B gene, a major causative gene of congenital central hypoventilation syndrome. , 2004, The Tohoku journal of experimental medicine.
[25] R. Ravazzolo,et al. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome , 2004, Journal of Medical Genetics.
[26] B. Maher,et al. Idiopathic congenital central hypoventilation syndrome: Analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b , 2003, American journal of medical genetics. Part A.
[27] Michael J Ackerman,et al. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. , 2003, Mayo Clinic proceedings.
[28] H. Kinney,et al. Serotonergic Brainstem Abnormalities in Northern Plains Indians with the Sudden Infant Death Syndrome , 2003, Journal of neuropathology and experimental neurology.
[29] Tomohiko Nakamura,et al. Molecular analysis of congenital central hypoventilation syndrome , 2003, Human Genetics.
[30] B. Maher,et al. Association of the serotonin transporter gene with sudden infant death syndrome: A haplotype analysis , 2003, American journal of medical genetics. Part A.
[31] M. Garcia-Barceló,et al. Association study of PHOX2B as a candidate gene for Hirschsprung’s disease , 2003, Gut.
[32] R. Rosmond,et al. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria , 2003, Psychoneuroendocrinology.
[33] A. Munnich,et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome , 2003, Nature Genetics.
[34] R. Krumlauf,et al. Coordinated temporal and spatial control of motor neuron and serotonergic neuron generation from a common pool of CNS progenitors. , 2003, Genes & development.
[35] B. Maher,et al. Sudden infant death syndrome: Association with a promoter polymorphism of the serotonin transporter gene , 2003, American journal of medical genetics. Part A.
[36] V. Bubb,et al. The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit , 2003, The European journal of neuroscience.
[37] M. Egan,et al. Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.
[38] N. Okado,et al. Alteration of serotonergic receptors in the brain stems of human patients with respiratory disorders. , 2002, Neuropediatrics.
[39] Tianhua Niu,et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. , 2002, JAMA.
[40] J. Towbin,et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. , 2001, JAMA.
[41] G. Breithardt,et al. Molecular diagnosis in a child with sudden infant death syndrome , 2001, The Lancet.
[42] A. Miniño,et al. Deaths: preliminary data for 2000. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[43] K R Nielsen,et al. Acute exposure to environmental tobacco smoke and heart rate variability. , 2001, Environmental health perspectives.
[44] M. Yanagisawa,et al. Impaired Ventilatory Responses to Hypoxia in Mice Deficient in Endothelin-Converting-Enzyme-1 , 2001, Pediatric Research.
[45] B. Maher,et al. Case/control family study of autonomic nervous system dysfunction in idiopathic congenital central hypoventilation syndrome. , 2001, American journal of medical genetics.
[46] B. Maher,et al. Genetic segregation analysis of autonomic nervous system dysfunction in families of probands with idiopathic congenital central hypoventilation syndrome. , 2001, American journal of medical genetics.
[47] S. Takashima,et al. Serotonin Transporter Gene Variation Is a Risk Factor for Sudden Infant Death Syndrome in the Japanese Population , 2001, Pediatrics.
[48] G. Breithardt,et al. Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .
[49] P. Hrdina,et al. Gender differences in association between serotonin transporter gene polymorphism and personality traits. , 2000, Psychiatric genetics.
[50] S. Priori,et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. , 2000, The New England journal of medicine.
[51] H. Kinney,et al. Decreased Serotonergic Receptor Binding in Rhombic Lip‐Derived Regions of the Medulla Oblongata in the Sudden Infant Death Syndrome , 2000, Journal of neuropathology and experimental neurology.
[52] Andreas Heinz,et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity , 2000, Biological Psychiatry.
[53] B. Greenberg,et al. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior , 2000, Molecular Psychiatry.
[54] Y. Osher,et al. Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs , 2000, Molecular Psychiatry.
[55] S. Korsmeyer,et al. Rnx deficiency results in congenital central hypoventilation , 2000, Nature Genetics.
[56] P. Franco,et al. Influence of Maternal Smoking on Autonomic Nervous System in Healthy Infants , 2000, Pediatric Research.
[57] F. Zhou,et al. Expression of serotonin transporter protein in developing rat brain. , 2000, Brain research. Developmental brain research.
[58] J. Quinn,et al. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[59] D. Tester,et al. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. , 1999, Mayo Clinic proceedings.
[60] S. Priori,et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. , 1999, The American journal of cardiology.
[61] C. Fiskerstrand,et al. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells , 1999, FEBS letters.
[62] T. Arinami,et al. Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population. , 1999, Alcoholism, clinical and experimental research.
[63] P. Franco,et al. Decreased Autonomic Responses to Obstructive Sleep Events in Future Victims of Sudden Infant Death Syndrome , 1999, Pediatric Research.
[64] X. Morin,et al. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives , 1999, Nature.
[65] D. Blackwood,et al. Presence of Multiple Functional Polyadenylation Signals and a Single Nucleotide Polymorphism in the 3′ Untranslated Region of the Human Serotonin Transporter Gene , 1999, Journal of neurochemistry.
[66] David J. Anderson,et al. Specification of Neurotransmitter Identity by Phox2 Proteins in Neural Crest Stem Cells , 1999, Neuron.
[67] K K Kidd,et al. Population studies of polymorphisms of the serotonin transporter protein gene. , 1999, American journal of medical genetics.
[68] Hiroshi Kunugi,et al. Association between serotonin transporter gene polymorphism and anxiety-related traits , 1999, Biological Psychiatry.
[69] R. Hauer,et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). , 1999, Journal of the American College of Cardiology.
[70] L. Siever,et al. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. , 1998, The American journal of psychiatry.
[71] D. Kupfer,et al. How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? , 1998, The American journal of psychiatry.
[72] P. Schwartz,et al. Prolongation of the QT interval and the sudden infant death syndrome. , 1998, The New England journal of medicine.
[73] M. Ledwidge,et al. Neurocardiogenic syncope: a model for SIDS , 1998, Archives of disease in childhood.
[74] P. Shields,et al. The role of the serotonin transporter gene in cigarette smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[75] M. Hirsch,et al. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. , 1998, Development.
[76] D. Anderson,et al. MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. , 1998, Development.
[77] E H Cook,et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. , 1998, The American journal of psychiatry.
[78] M. Spitz,et al. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[79] D. Cook,et al. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. , 1997, Thorax.
[80] E. Mitchell,et al. Risk factors for sudden infant death syndrome following the prevention campaign in New Zealand: a prospective study. , 1997, Pediatrics.
[81] X. Morin,et al. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. , 1997, Development.
[82] P. Blair,et al. Giving thyroid hormones to clinically hypothyroid but biochemically euthyroid patients , 1997, BMJ.
[83] S. Kanba,et al. Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. , 1997, American journal of medical genetics.
[84] H. Hoffman,et al. Sudden infant death syndrome and smoking in the United States and Sweden. , 1997, American journal of epidemiology.
[85] G. Brüning,et al. Prenatal development of the serotonin transporter in mouse brain , 1997, Cell and Tissue Research.
[86] H. Brown,et al. Case-control study of sudden infant death syndrome in Scotland, 1992-5 , 1997, BMJ.
[87] D. Shannon,et al. RET proto-oncogene is important for the development of respiratory CO2 sensitivity. , 1997, Journal of the autonomic nervous system.
[88] R. Murray,et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. , 1996, Molecular psychiatry.
[89] K. Lesch,et al. Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.
[90] E. Mitchell,et al. Symptoms, sweating and reactivity of infants who die of SIDS compared with community controls , 1996, Journal of paediatrics and child health.
[91] P. J. Fleming,et al. Smoking and the sudden infant death syndrome: results from 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy , 1996 .
[92] R. Murray,et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. , 1996, Neuroreport.
[93] P Riederer,et al. Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.
[94] A Malliani,et al. A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects. , 1996, Cardiovascular research.
[95] G. Goodwin,et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.
[96] J. Lauder,et al. Serotonin regulates mouse cranial neural crest migration. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[97] M. Kotamäki. Smoking induced differences in autonomic responses in military pilot candidates , 1995, Clinical Autonomic Research.
[98] S. Piha. Cardiovascular autonomic reflexes in heavy smokers. , 1994, Journal of the autonomic nervous system.
[99] Mary T. Carbone,et al. Cardiorespiratory recordings from infants dying suddenly and unexpectedly at home. , 1994, Pediatrics.
[100] M. Marazita,et al. Congenital central hypoventilation syndrome: inheritance and relation to sudden infant death syndrome. , 1993, American journal of medical genetics.
[101] D L Eckberg,et al. Influence of Cigarette Smoking on Human Autonomic Function , 1993, Circulation.
[102] K. Nakachi,et al. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. , 1993, Cancer research.
[103] R. Blakely,et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[104] K. Kawajiri,et al. High Susceptibility to Lung Cancer Analyzed in Terms of Combined Genotypes of P450IA1 and Mu‐class Glutathione S‐Transferase Genes , 1992, Japanese journal of cancer research : Gann.
[105] J. Groswasser,et al. Sleep and cardiorespiratory characteristics of infant victims of sudden death: a prospective case-control study. , 1992, Sleep.
[106] T. Dwyer,et al. Thermal environment and sudden infant death syndrome: case-control study. , 1992, BMJ.
[107] R. Gilbert,et al. Interaction between bedding and sleeping position in the sudden infant death syndrome: a population based case-control study. , 1990, BMJ.
[108] H. Hoffman,et al. Cardiac and respiratory patterns in normal infants and victims of the sudden infant death syndrome. , 1988, Sleep.
[109] B. Maron,et al. Potential Role of QT Interval Prolongation in Sudden Infant Death Syndrome , 1976, Circulation.
[110] P. Schwartz. Cardiac sympathetic innervation and the sudden infant death syndrome. A possible pathogenetic link. , 1976, The American journal of medicine.
[111] P. Riederer,et al. Organization of the human serotonin transporter gene , 2005, Journal of Neural Transmission / General Section JNT.
[112] H. Bartsch,et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[113] D. Shannon,et al. Idiopathic congenital central hypoventilation syndrome: diagnosis and management. American Thoracic Society. , 1999, American journal of respiratory and critical care medicine.
[114] J. A. Martin,et al. ADVANCE REPORT OF FINAL NATALITY STATISTIC, 1992 , 1994 .
[115] H. Kinney,et al. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. , 1994, Biology of the neonate.
[116] B. Jacobs,et al. Structure and function of the brain serotonin system. , 1992, Physiological reviews.